» Articles » PMID: 35450085

Geographic Variation of Infectious Disease Diagnoses Among Patients With Fever of Unknown Origin: A Systematic Review and Meta-analysis

Overview
Date 2022 Apr 22
PMID 35450085
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fever of unknown origin (FUO) investigations yield a substantial number of patients with infectious diseases. This systematic review and meta-analysis aimed to quantify more common FUO infectious diseases etiologies and to underscore geographic variation.

Methods: Four databases (PubMed, Embase, Scopus, and Web of Science) were searched for prospective studies reporting FUO rates among adult patients from 1 January 1997 to 31 March 2021. The pooled proportion for infectious diseases etiology was estimated using the random-effects meta-analysis model.

Results: Nineteen prospective studies were included with 2667 total cases. No studies were available for Africa or the Americas. Overall, 37.0% (95.0% confidence interval [CI], 30.0%-44.0%) of FUO patients had an infectious disease etiology. Infections were more likely from Southeastern Asia (pooled proportion, 0.49 [95% CI, .43-.55]) than from Europe (pooled proportion, 0.31 [95% CI, .22-.41]). Among specifically reported infectious diseases (n = 832), complex predominated across all geographic regions (n = 285 [34.3%]), followed by brucellosis (n = 81 [9.7%]), endocarditis (n = 62 [7.5%]), abscesses (n = 61 [7.3%]), herpesvirus (eg, cytomegalovirus and Epstein-Barr virus) infections (n = 60 [7.2%]), pneumonia (n = 54 [6.5%]), urinary tract infections (n = 54 [6.5%]), and enteric fever (n = 40 [4.8%]).

Conclusions: FUO patients from Southeastern Asia were more likely to have an infectious diseases etiology when compared to other regions. The predominant factor for this finding appears to be differences in disease prevalence among various geographical locations or other factors such as access to timely care and diagnosis. Noting epidemiological disease factors in FUO investigations could improve diagnostic yields and clinical outcomes.

Citing Articles

Onco-mNGS facilitates rapid and precise identification of the etiology of fever of unknown origin: a single-centre prospective study in North China.

Liu B, Yu T, Ren R, Wu N, Xing N, Wang J BMC Infect Dis. 2024; 24(1):1475.

PMID: 39732661 PMC: 11682622. DOI: 10.1186/s12879-024-10383-3.


Recommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel.

Wright W, Stelmash L, Betrains A, Mulders-Manders C, Rovers C, Vanderschueren S Open Forum Infect Dis. 2024; 11(7):ofae298.

PMID: 38966848 PMC: 11222709. DOI: 10.1093/ofid/ofae298.


Nuclear Medicine Imaging Tools in Fever of Unknown Origin: Time for a Revisit and Appropriate Use Criteria.

Wright W, Kandiah S, Brady R, Shulkin B, Palestro C, Jain S Clin Infect Dis. 2024; 78(5):1148-1153.

PMID: 38441140 PMC: 11093677. DOI: 10.1093/cid/ciae115.


Infectious causes of fever of unknown origin in developing countries: An international ID-IRI study.

Erdem H, Al-Tawfiq J, Abid M, Yahia W, Akafity G, Ramadan M J Intensive Med. 2024; 4(1):94-100.

PMID: 38263972 PMC: 10800762. DOI: 10.1016/j.jointm.2023.07.004.


Unraveling the mystery of fever of unknown origin: a remarkable journey towards the diagnosis of peripheral T-cell lymphoma-T follicular helper type: A rare case report.

Trifonov P, Koltchakov V, Mihaylova-Garnizova R, Yordanov A, Sokolova L, Nikolov R Medicine (Baltimore). 2024; 103(3):e36974.

PMID: 38241538 PMC: 10798690. DOI: 10.1097/MD.0000000000036974.


References
1.
Torne Cachot J, Baucells Azcona J, Blanch Falp J, Camell Ilari H . Classic fever of unknown origin: analysis of a cohort of 87 patients according to the definition with qualitative study criterion. Med Clin (Barc). 2020; 156(5):206-213. DOI: 10.1016/j.medcli.2020.03.014. View

2.
Altiparmak M, Apaydin S, Ataman R, Tabak F, Mert A, Serdengecti K . Fever of unknown origin in uremic patients: a controlled prospective study. Scand J Infect Dis. 2002; 33(11):851-3. DOI: 10.1080/713933774. View

3.
Wright W, Simner P, Carroll K, Auwaerter P . Progress Report: Next-Generation Sequencing, Multiplex Polymerase Chain Reaction, and Broad-Range Molecular Assays as Diagnostic Tools for Fever of Unknown Origin Investigations in Adults. Clin Infect Dis. 2021; 74(5):924-932. DOI: 10.1093/cid/ciab155. View

4.
Manfredi R, Calza L, Chiodo F . Primary cytomegalovirus infection in otherwise healthy adults with Fever of unknown origin: a 3-year prospective survey. Infection. 2006; 34(2):87-90. DOI: 10.1007/s15010-006-5012-0. View

5.
Chin C, Shin-Jung Lee S, Chen Y, Wann S, Lin H, Lin W . Mycobacteriosis in patients with fever of unknown origin. J Microbiol Immunol Infect. 2004; 36(4):248-53. View